1 drug(s) with this reaction
2,621 total reports
Platelet Count Decreased has been reported as an adverse reaction across 1 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,621 adverse event reports mention platelet count decreased in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with platelet count decreased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have platelet count decreased listed in their FDA adverse event reports, sorted by report count:
In addition to platelet count decreased, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
1 drug(s) manufactured by Abbvie Inc have platelet count decreased listed in their FDA adverse event reports: VENETOCLAX.
There are a combined 2,621 reports of platelet count decreased across 1 Abbvie Inc drug(s) in the FDA adverse event database.